Logo
Richesse EXO19

Richesse EXO19

Richesse

Skin Booster
  • Formulated with FDA Approved ingredients according to manufacturer and distributor descriptions.
  • Produced by JDBIO Co., Ltd. under GMP Like quality standards and high Purity exosome refining processes.
  • Marketed as a professional cosmetic/aesthetic skin booster; regulatory classification (cosmetic vs. medical device) may vary by country and should be checked locally before clinical use.
  • Intended only for professional use in compliance with local regulations governing exosome Based and regenerative aesthetic treatments.
Liquid immune exosome skin booster for regenerative aesthetics

Description

Richesse EXO19 is a next-generation liquid immune exosome skin booster engineered for intensive skin regeneration and repair. Powered by high-purity immune exosomes derived from advanced DLC (Dynamic Linked Cell) / TPC (TEXsome Progenitor Cell) technology, EXO19 delivers a concentrated dose of regenerative exosomes that work at a cellular level to accelerate skin repair, normalise skin function and improve barrier integrity. The fast-absorbing 2.2 ml ready-to-use serum contains 19 active ingredients, including hyaluronic acid, peptides, glutathione, niacinamide, sodium DNA (PN) and cica, formulated with FDA-approved ingredients. Clinically tested for skin regeneration, Richesse EXO19 demonstrates rapid cell migration, enhanced tissue recovery, improved skin barrier function and visible improvement in irritated or damaged skin within 24 hours of application. Suitable for professional skin booster protocols on the face, neck, décolletage, hands and other areas in need of regeneration, it supports smoother, brighter, more elastic and resilient skin with minimal downtime.

Bnefits

  • Utilises high-purity immune exosomes derived from advanced DLC / TPC technology to accelerate natural skin repair and regeneration.
  • Works at a cellular level to enhance cell communication, promoting collagen and elastin synthesis and improving overall skin quality.
  • Helps normalise skin function and strengthen the skin barrier, leading to a healthier, more resilient complexion.
  • Contains 19 active ingredients including hyaluronic acid, peptides, glutathione, sodium DNA (PN), niacinamide and cica for multi-dimensional anti-ageing and brightening effects.
  • Supports rapid tissue recovery and cell migration, with clinically observed improvement in irritated and damaged skin within 24 hours.
  • Improves skin texture, elasticity and radiance, addressing signs of ageing, dullness and uneven tone.
  • Contributes to stronger skin immunity and resistance to environmental stressors through immune exosome signalling and antioxidant components.
  • Fast-absorbing, ready-to-use liquid format ensures efficient penetration and easy integration into professional aesthetic protocols.
  • Produced using high-efficiency exosome manufacturing (up to 100x production capacity vs conventional methods) with high-purity refining and stringent quality control.
  • Designed for professional use in clinics as a high-performance skin booster, complementing other aesthetic procedures such as microneedling, mesotherapy and injectables.

Indications

  • Facial skin rejuvenation targeting fine lines, early wrinkles and loss of elasticity.
  • Improvement of skin tone, texture and radiance in dull, tired or photo-damaged skin.
  • Supportive treatment for compromised skin barrier, irritation and post-procedure recovery (per professional judgement).
  • Neck and décolletage rejuvenation where improved elasticity and brightness are desired.
  • Hand rejuvenation to address texture changes and loss of vitality.
  • Adjunctive regenerative treatment for areas requiring enhanced healing and tissue quality, including scalp or other sites where permitted by local protocols.
  • Skin types concerned with hyperpigmentation, firmness and overall anti-ageing benefits, as indicated by exosome and active ingredient profile.

Composition

  • Liquid immune exosomes derived from immune progenitor cells using DLC (Dynamic Linked Cell) / TPC (TEXsome Progenitor Cell) technology (average exosome size ~98.5 nm).
  • Hyaluronic acid for hydration, volume support and improved extracellular matrix environment.
  • Sodium DNA (PN – polynucleotides) to support tissue regeneration, cell repair and dermal remodelling.
  • Peptides with regenerative, firming and anti-ageing activity.
  • Glutathione as a key antioxidant and skin-brightening agent.
  • Niacinamide (Vitamin B3) for barrier support, brightening and anti-inflammatory benefits.
  • Centella asiatica extract (cica) for soothing and tissue-repair support.
  • Additional functional actives (total 19 active ingredients) aimed at brightening, firming and improving hyperpigmentation.
  • Buffered aqueous solution with FDA-approved excipients suitable for professional cosmetic/aesthetic use (full INCI list available from manufacturer).

Formulation

  • Liquid immune exosome skin booster in serum form.
  • Ready-to-use, fast-absorbing liquid for topical, microneedling-assisted or mesotherapy-style application per professional protocol.
  • 2.2 ml sterile vial providing a single treatment or multi-area application depending on protocol.
  • Formulated exclusively with FDA-approved ingredients according to manufacturer and distributor information.
  • High-purity exosome refining process with strict quality control to ensure consistent size distribution and potency.
  • Designed for intensive regenerative aesthetics and integration into advanced skin booster protocols.

Packaging

  • Single-unit box containing 1 x 2.2 ml vial of Richesse EXO19 liquid immune exosome solution.
  • Vial supplied sterile; outer carton labelled with product name (RICHESSE EXO19), volume (2.2 ml), main active description (Liquid Immune Exosome) and brand (RICHESSE / EXO’ONE depending on market).
  • Carton includes batch/lot number, expiry date and manufacturer information (JDBIO Co., Ltd.).
  • Intended for professional-use environments such as aesthetic clinics and medical practices; ancillary items (needles, syringes, microneedling devices) are not typically included and must be sourced separately.

Usage

  • For professional use only: Richesse EXO19 should be used exclusively by qualified medical or aesthetic practitioners trained in exosome-based skin booster protocols.
  • Prior to treatment, take a full medical history including skin conditions, allergies (especially to cosmetic actives, exosome formulations or any listed ingredients), medications and previous aesthetic procedures; obtain informed consent.
  • Cleanse the treatment area thoroughly and disinfect with an appropriate antiseptic according to clinic protocol.
  • Open the 2.2 ml vial aseptically; draw the required amount into a sterile syringe or device reservoir depending on the chosen delivery method.
  • Richesse EXO19 may be applied via professional techniques such as: microneedling (MTS) or stamping devices, superficial mesotherapy/nappage injections, or post-energy device topical application, according to clinic protocol and local regulations.
  • When using microneedling or stamping devices, adjust needle depth to a superficial to mid-dermal level appropriate for the indication and skin type, ensuring uniform coverage while avoiding excessive trauma.
  • If used with superficial injection techniques, inject small aliquots in a grid or linear pattern into the superficial dermis or subdermis per practitioner judgement; avoid intravascular injection and high-risk anatomical zones.
  • Distribute the product evenly across treatment areas such as face, neck, décolletage or hands, focussing on regions with more pronounced ageing or damage.
  • After application, gently massage or pat the skin if indicated by the chosen technique, and apply a soothing post-procedure product and broad-spectrum sunscreen where appropriate.
  • Typical protocols involve a series of sessions (for example, every 2–4 weeks for several treatments) depending on skin condition, with maintenance sessions scheduled as clinically appropriate.
  • Instruct patients to avoid makeup on the treated area for the rest of the day, minimise sun exposure, and avoid saunas, intense exercise and alcohol for 24–48 hours post-treatment, following clinic-specific aftercare guidance.
  • Discard any remaining product in an opened vial at the end of the session; exosome solutions are single-use and must not be stored for later use.
  • Dispose of all used needles, syringes and consumables in appropriate sharps and clinical waste containers.

Contraindications

  • Known hypersensitivity or allergy to any component of the formulation (e.g. hyaluronic acid, niacinamide, peptides, glutathione, cica or other listed excipients).
  • Active skin infections, inflammatory dermatoses, open wounds or severe acne in the intended treatment area.
  • History of severe allergic reactions or anaphylaxis to injectable or device-assisted cosmetic treatments.
  • Pregnancy and breastfeeding (use is generally not recommended due to limited safety data for exosome-based products).
  • Severe systemic diseases or immune disorders, unless assessed and approved by a physician experienced with regenerative aesthetic treatments.
  • Use in patients on strong anticoagulation or immunosuppressive therapy without careful risk–benefit evaluation and appropriate precautions.
  • Known tendency to keloid or hypertrophic scar formation in the proposed treatment area when invasive delivery methods (e.g. microneedling, injections) are used.

Adverse Effects

  • Transient erythema (redness), mild swelling and warmth at the treatment site, especially when used with microneedling or mesotherapy techniques.
  • Mild discomfort, tightness or sensitivity in treated areas immediately after the procedure.
  • Pinpoint bleeding or minor bruising when used with needling or injection-based delivery.
  • Short-term dryness or flaking as the skin renews, particularly after initial treatments.
  • Rare local irritation or sensitivity reactions to one or more active ingredients, presenting as persistent redness, itching or burning; discontinue use and evaluate if symptoms persist.
  • Low but possible risk of infection if aseptic technique is not strictly followed or if patients do not adhere to aftercare instructions.
  • When injections are used, standard injection-related risks apply (e.g. haematoma, nodules, vascular compromise), and appropriate emergency protocols should be in place, although EXO19 itself is a liquid serum rather than a volumising filler.

Storage Conditions

  • Store in a cool, dry place away from direct sunlight and sources of heat, according to manufacturer and distributor recommendations.
  • Avoid freezing the product and do not expose it to temperature extremes outside the recommended range stated on the packaging.
  • Keep vials in their original packaging until use to maintain sterility and protect from light.
  • Do not use after the expiry date printed on the vial and outer carton.
  • Once opened, use immediately for a single session and discard any remaining product; do not reuse or attempt to resterilise.
  • Keep out of the sight and reach of children and untrained personnel.

Duration

Results and duration vary by patient and protocol, but clinical and distributor information suggests progressive improvements in texture, elasticity and radiance over several weeks, with benefits that can persist for months after a course of treatments when maintenance sessions are performed.

Onset

Hydration and radiance often improve within days of treatment, with biopsy and clinical observations indicating visible improvement in irritated or damaged skin within approximately 24 hours; structural and textural benefits from exosome-driven regeneration typically build over several weeks.

Browse more Skin Booster

Top Treatments

Top Cities in the UK